Posted Aug. 29, 2012 at 5:23 a.m.
Lung disease
Image 1 of 2 · Next Image…
Patients taking Novartis's QVA149 were able to expel more air from their lungs in one second than those receiving Glaxo's best-selling Advair after 26 weeks of treatment, according to a summary of data from a trial....
Novartis smoker's cough drug beats GSK's Advair in trial
Post a comment
Print this blog postE-mail blog post
Share
Lung disease
Image 1 of 2 · Next Image…
Patients taking Novartis's QVA149 were able to expel more air from their lungs in one second than those receiving Glaxo's best-selling Advair after 26 weeks of treatment, according to a summary of data from a trial....
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 Bloomberg. All rights reserved.Please log in or register to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
Big Blue layoff count nears 2,800 in North America alone- NC's high-tech job picture improves in May, but ...
- IBM layoff count hits nearly 2,300 across 31 work groups
- NC IDEA: Startup deal flow 'better than it has ever been'
- IBM's job cuts are global, nearing 4,000; most are in U.S.
- CEO fears for future of NC Biofuels Center due to budget cuts
- Workers 50+ take biggest hit among 14% reduction in IBM marketing group
- 'Anxiety and disruption:' IBM's form letter for layoffs
- 'Hundreds' of IBMers across NC hit with layoff notices
- IBM begins job cuts in RTP, across US, Canada, workers report